Struma ovarii screening: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}  
==Overview==
==Overview==
There is insufficient evidence to recommend routine screening for Struma ovarii
There is insufficient evidence to recommend routine screening for Struma ovarii.


==Screening==
==Screening==

Revision as of 15:43, 18 August 2017

Struma ovarii Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Struma ovarii from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Struma ovarii screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Struma ovarii screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Struma ovarii screening

CDC on Struma ovarii screening

Struma ovarii screening in the news

Blogs on Struma ovarii screening

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Struma ovarii screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There is insufficient evidence to recommend routine screening for Struma ovarii.

Screening

  • There is insufficient evidence to recommend routine screening for Struma ovarii.
  • However, in cases of metastatic struma ovarii post total thyroidectomy along with radioiodine scanning and radioiodine ablation, the thyroglobulin levels must be monitored as a tumor marker, and diagnostic radioiodine scans should be done to screen for residual or recurrent disease. [1] [2]

References

  1. McGill JF, Sturgeon C, Angelos P (2009). "Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation". Endocr Pract. 15 (2): 167–73. doi:10.4158/EP.15.2.167. PMID 19289330.
  2. McGill, Julie; Sturgeon, Cord; Angelos, Peter (2009). "Metastatic Struma Ovarii Treated with Total Thyroidectomy and Radioiodine Ablation". Endocrine Practice. 15 (2): 167–173. doi:10.4158/EP.15.2.167. ISSN 1530-891X.

Template:WH Template:WS